Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA4 | P22748 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA5A | P35218 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | FYN | P06241 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30013888 | 1.00 | TDP1 (0.44) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| SCHEMBL1491272 | 0.81 | ALDH1A1 (0.48) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| SCHEMBL250199 | 0.81 | ALDH1A1 (0.55) | TDP1ALDH1A1HSD17B10CA2CA4 | |
| SCHEMBL11413280 | 0.79 | CDK2 (0.44) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| SCHEMBL11149914 | 0.79 | CA2 (0.47) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| SCHEMBL29381412 | 0.79 | TDP1 (0.50) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| SCHEMBL18837 | 0.79 | TDP1 (0.50) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| SCHEMBL190005 | 0.79 | TDP1 (0.50) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| Catechol SCHEMBL1491270 | 0.78 | ALDH1A1 (0.62) | TDP1ALDH1A1HSD17B10CDK2CA2 | |
| SCHEMBL899804 | 0.78 | CDK2 (0.68) | TDP1ALDH1A1HSD17B10CDK2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110658137-B | Combined measurement method for measuring contents of niobium and phosphorus in ferrocolumbium | 广东韶钢松山股份有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-112697732-B | Method for detecting niobium content in alloy | 攀钢集团江油长城特殊钢有限公司 | 2022-05-03 | — | — | CN | claimed |
| CN-112697732-A | Method for detecting niobium content in alloy | 攀钢集团江油长城特殊钢有限公司 | 2021-04-23 | — | — | CN | claimed |
| CN-110658137-A | Combined measurement method for measuring niobium and phosphorus content in ferrocolumbium | 广东韶钢松山股份有限公司 | 2020-01-07 | — | — | CN | claimed |
| US-6727359-B2 | REACTING PHENOXIDE SULFONYLCHLORIDE AND ACETOACETAMIDE-N-SULFONYL PHENOXIDE AND AMMONIA USING CATALYST | BDL CORPORATION | 2004-04-27 | — | — | US | claimed |
| US-20030065172-A1 | Composition comprising 6-methyl-3,4dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide, its salts, preparation thereof and uses therefor | BDL CORPORATION | 2003-04-03 | — | — | US | claimed |
| US-11787837-B2 | DCHBS-active esters of PEG compounds and their use | NOVO NORDISK A/S (DK) | 2023-10-17 | — | — | US | disclosed |
| CN-109922835-B | DCHBS active ester of PEG compound and application thereof | 诺和诺德股份有限公司 | 2023-08-04 | — | — | CN | disclosed |
| US-20230022304-A1 | WDR5-MYC INHIBITORS | VANDERBILT UNIVERSITY | 2023-01-26 | — | — | US | disclosed |
| CN-110658137-B | Combined measurement method for measuring contents of niobium and phosphorus in ferrocolumbium | 广东韶钢松山股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-110658137-B | Combined measurement method for measuring contents of niobium and phosphorus in ferrocolumbium | 广东韶钢松山股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| CN-112697732-B | Method for detecting niobium content in alloy | 攀钢集团江油长城特殊钢有限公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-113916875-A | Method for determining element niobium in high-temperature alloy | 中国航发北京航空材料研究院 | 2022-01-11 | — | — | CN | disclosed |
| US-4861913-A | Bicyclic sulfonamide derivatives | SHIONOGI & CO., LTD. (JP) | 1989-08-29 | — | — | US | disclosed |
| EP-0226346-A1 | Bicyclic sulfonamide derivatives | SHIONOGI & CO., LTD. (JP) | 1987-06-24 | — | — | EP | disclosed |
| EP-0061071-B1 | ACTIVATED APOGLUCOSE OXIDASE, METHOD OF PREPARING IT, ITS USE IN SPECIFIC BINDING ASSAY METHODS AND REAGENT MEANS AND TEST KITS CONTAINING IT | MILES LABORATORIES, INC. (US) | 1985-05-29 | — | — | EP | disclosed |
| US-4443536-A | CONTAINING BALLAST WITH HYDROXYPHENYLSULFINYL OR HYDROXYPHENYLSULFONYL GROUP | EASTMAN KODAK COMPANY (US) | 1984-04-17 | — | — | US | disclosed |
| US-4388246-A | THERMAL SPLITTING OF CARBAMATES | BAYER AKTIENGESELLSCHAFT (DE) | 1983-06-14 | — | — | US | disclosed |
| EP-0073636-A1 | Photographic elements containing ballasted couplers | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1983-03-09 | — | — | EP | disclosed |
| EP-0061013-A1 | Process for the preparation of polyisocyanates | BAYER AG (DE) | 1982-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030065172-A1 | Composition comprising 6-methyl-3,4dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide, its salts, preparation thereof and uses therefor | PDXK, ITK, KHK | TDP1 4639/4885ALDH1A1 636/4885HSD17B10 1156/4885 |
| US-20230022304-A1 | WDR5-MYC INHIBITORS | MYC, WDR5, MYCBP | TDP1 3147/4885ALDH1A1 3982/4885HSD17B10 3101/4885 |
| US-11787837-B2 | DCHBS-active esters of PEG compounds and their use | HBB, IAPP, GLP1R | TDP1 4759/4885ALDH1A1 4448/4885HSD17B10 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.